Related Experiment Video
Updated: Aug 13, 2026

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Longitudinal Effects of Congenital Heart Defects in Infants With Down Syndrome: Implications for Developmental
Faith A Albertson1, Kali Kecskemeti2, Karl B Gregory2
1University of North Carolina at Chapel Hill, Chapel Hill, NC.
Insights
Congenital heart defects (CHDs) in infants with Down syndrome (DS) did not impact development at 12 months. However, DS infants with CHDs showed better expressive language at 24 months.
Area of Science:
- Pediatrics
- Developmental Neuroscience
- Genetics
Background:
- Congenital heart defects (CHDs) are common in infants with Down syndrome (DS), affecting 40-58%.
- Limited evidence exists on how CHDs impact neurodevelopmental trajectories in DS.
- Understanding these effects is crucial for targeted interventions.
Purpose of the Study:
- To investigate the effects of cooccurring CHDs on neurodevelopmental outcomes in children with DS.
- To examine developmental trajectories from 12 to 24 months of age.
- To explore potential moderating factors like therapy.
Main Methods:
- Longitudinal study of 47 children with DS (26 with CHD) from 12 to 24 months.
- Assessment of cognitive, motor, and language abilities.
- Analysis of therapy type and dose effects.
Main Results:
- No significant developmental differences between DS and DS+CHD groups at 12 months.
- Children with DS+CHD demonstrated significantly higher expressive language at 24 months.
- Therapy type and dose showed varied buffering effects across groups and ages.
Conclusions:
- Neurodevelopmental outcomes in children with DS vary, even with cooccurring CHDs.
- The presence of CHD may influence specific developmental areas, like language, over time.
- Findings suggest the need for individualized treatment approaches for children with DS.
Abstract:
Cooccurring congenital heart defects (CHDs) affect roughly 40% to 58% of infants with Down syndrome (DS). However, evidence on the variation and timing by which CHDs affect neurodevelopmental outcomes, including cognition, motor, and language abilities in DS is limited. The present study investigated effects of CHD on these neurodevelopmental outcomes from 12 to 24 months in N = 47 children with DS (n = 26 with cooccurring CHD). No significant developmental differences were found between infants with DS only and infants with DS+CHD at 12 months. Unexpectedly, children with DS+CHD showed significantly higher expressive language abilities at 24 months compared to children with DS only. Post-hoc analyses investigated possible buffering effects of therapy type and dose across ages, identifying different patterns across groups. Findings highlight the variation in developmental outcomes for children with DS+CHD broadly, and implications for targeted treatment for all children with DS are discussed.
Related Concept Videos
Meiosis I
Teratogenicity
Mitral Stenosis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Longitudinal Studies
Neurulation
